Table 1. Characteristics.
| n = 121 | |
|---|---|
| Age (years) | 70.3 ± 9.4 |
| Sex | |
| Male (n, %) | 81 (66.9) |
| Stage (n = 118) | |
| Stage I-II | 74 (61.2) |
| Stage III | 44 (36.4) |
| Disease | |
| Colorectal cancer | 82 (67.8) |
| Stomach cancer | 39 (32.2) |
| Charlson comorbidity index (points) | |
| 2 | 78 (64.5) |
| 3 | 31 (25.6) |
| 4 | 10 (8.3) |
| 5 | 2 (1.7) |
| CEA (ng/mL) (n = 117) | 21.7 ± 3.8 |
| CA19-9 (U/mL) (n = 113) | 42.4 ± 161.8 |
| CRP (mg/dL) (n = 104) | 0.7 ± 1.5 |
| Albumin (g/dL) (n = 105) | 3.6 ± 0.6 |
| Hemoglobin (g/dL) (n =107) | 12.0 ± 2.6 |
| HbA1c (%) (n = 92) | 6.1 ± 0.9 |
| PNI (points) (n = 100) | 45.0 ± 7.0 |
| BMI (kg/m2) | |
| Male | 21.7 ± 3.8 |
| Female | 21.0 ± 3.5 |
| SMI (kg/m2) | |
| Male | 6.8 ± 1.1 |
| Female | 5.5 ± 0.8 |
| VFA (cm2) | |
| Male (n = 77) | 108.2 ± 62.9 |
| Female (n = 39) | 115.2 ± 77.9 |
| Body fat (%) | |
| Male | 22.3 ± 7.2 |
| Female | 30.4 ± 9.0 |
Data were expressed as n (%) or mean ± SD.